Prevalence of Atrial Fibrillation in Patients with High CHADS(2)- and CHA(2)DS(2)VAS(c)-Scores: Anticoagulate or Monitor High-Risk Patients?

Documenti analoghi

• Comparison of CHADS(2) and CHA(2)DS(2)-VAS(C) anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients
  di: Winkle, Roger A., et al.
  Pubblicazione: (2014)
• CHADS(2) and CHA(2)DS(2)Vasc-Score in Peripheral Systemic Embolism
  di: Santosa, Frans, et al.
  Pubblicazione: (2013)
• Using CHADS(2), R(2)CHADS(2), CHA(2)DS(2)-VASc score for mortality prediction in patients with abnormal low and high ankle-brachial index
  di: Chi, Nai-Yu, et al.
  Pubblicazione: (2021)
• Prediction of thromboembolic events and mortality by the CHADS(2) and the CHA(2)DS(2)-VASc in COVID-19
  di: Caro-Codón, Juan, et al.
  Pubblicazione: (2021)
• R(2(GFR))CHADS(2) and R(2(GFR))CHA(2)DS(2)VASc schemes improved the performance of CHADS(2) and CHA(2)DS(2)VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
  di: Fu, Shihui, et al.
  Pubblicazione: (2017)